- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.11. | Aquaporin A/S: Aquaporin Q3 2024 Trading Statement | 439 | GlobeNewswire (Europe) | Company announcement
No. 19/2024
Aquaporin A/S
Nymøllevej 78
DK-2800 Kongens Lyngby
aquaporin.com
Company registration no.: DK28315694
Copenhagen, Denmark, November 14, 2024 - Aquaporin A/S (ticker:... ► Artikel lesen | |
| 11.11. | AQUAPORIN A/S: Aquaporin secures milestone contract in Central Asia | 1 | Cision News | ||
| 07.11. | AQUAPORIN A/S: Aquaporin and Brenntag expand partnership to China | 25 | Cision News | ||
| 06.11. | Danish firm Aquaporin aims to expand footprint in China through CIIE | 1 | China Daily | ||
| 04.11. | AQUAPORIN A/S: The Next Generation of Aquaporin Inside® | 2 | Cision News | ||
| 25.10. | AQUAPORIN A/S: Aquaporin signs new contract with the European Space Agency | 2 | Cision News | ||
| 08.10. | AQUAPORIN A/S: Aquaporin lowers financial guidance for 2024 | 3 | Cision News | ||
| AQUAPORIN Aktie jetzt für 0€ handeln | |||||
| 24.08. | Aquaporin partners with Brenntag for APAC region & Turkiye | 5 | fibre2fashion | ||
| 23.08. | Aquaporin A/S: Aquaporin enters strategic partnership with industry leader Brenntag | 524 | PR Newswire | Company announcementNo. 17/2024
Aquaporin A/SNymøllevej 78DK-2800 Kongens Lyngbyaquaporin.comCompany registration no.: DK28315694
KONGENS LYNGBY, Denmark, Aug. 23, 2024 /PRNewswire/... ► Artikel lesen | |
| 22.08. | Aquaporin A/S: Aquaporin announces results for first half 2024 with revenue increase of 44% | 173 | GlobeNewswire (Europe) | Company announcement
No. 16/2024
Aquaporin A/S
Nymøllevej 78
DK-2800 Kongens Lyngby
aquaporin.com
Company registration no.: DK28315694
Kongens Lyngby, Denmark, August 22, 2024 - Aquaporin A/S... ► Artikel lesen | |
| 14.08. | AQUAPORIN A/S: Aquaporin to host half-year 2024 results webcast on August 22 | 1 | Cision News | ||
| 16.07. | AQUAPORIN A/S: Aquaporin-powered purifier now available in Turkey | 2 | Cision News | ||
| 11.07. | AQUAPORIN A/S: Aquaporin secures order with large EMEA water treatment company | 5 | Cision News | ||
| 29.05. | AQUAPORIN A/S: Aquaporin Expands in China: Launching New Products | 3 | Cision News | ||
| 23.05. | Aquaporin A/S: Aquaporin Q1 2024 Trading Statement - maintains guidance with strong orderbook | 250 | GlobeNewswire (Europe) | Aquaporin A/S, Nymøllevej 78, DK-2800 Kongens Lyngby, aquaporin.com, Company registration no.: DK28315694
Company announcement
No. 15/2024
Copenhagen, Denmark, May 23, 2024 - Aquaporin A/S (ticker:... ► Artikel lesen | |
| 29.04. | Nasdaq Copenhagen A/S: Aquaporin A/S -admittance to trading and official listing of new shares due to completion of rights issue | 262 | GlobeNewswire | The share capital of Aquaporin A/S has been increased. The admittance of
trading and official listing of new shares will take effect as per 30 April
2024 in the ISIN below.
ISIN: DK0061555109... ► Artikel lesen | |
| 25.04. | Aquaporin A/S: Aquaporin raises DKK 172 million | 341 | PR Newswire | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY... ► Artikel lesen | |
| 08.04. | XFRA CAPITAL ADJUSTMENT INFORMATION - 08.04.2024 | 820 | Xetra Newsboard | Das Instrument X2Y IT0005495871 YOLO GROUP S.P.A. O.N. EQUITY wird ex Kapitalmassnahme gehandelt am 08.04.2024 The instrument X2Y IT0005495871 YOLO GROUP S.P.A. O.N. EQUITY is traded ex capital adjustment... ► Artikel lesen | |
| 05.04. | Aquaporin A/S: Aquaporin publishes prospectus and initiates rights issue | 293 | PR Newswire | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY... ► Artikel lesen | |
| 05.04. | Nasdaq Copenhagen A/S: Aquaporin A/S - rights issue, admission to trading and official listing of subscription rights | 353 | GlobeNewswire | Subscription rights in Aquaporin A/S will be admitted to trading and official
listing on Nasdaq Copenhagen as per 8 April 2024. As of the same date, ISIN
DK0061555109 (AQP) will be traded excl. of subscription... ► Artikel lesen |
Seite:
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ADMA BIOLOGICS | 21,370 | 0,00 % | Adma Biologics Aktie: Erholung nach starkem Kursrückgang | ||
| RECURSION PHARMACEUTICALS | 6,040 | 0,00 % | Recursion Pharmaceuticals, Inc.: Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery | Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programsPlatform will... ► Artikel lesen | |
| EVOTEC | 9,910 | +0,05 % | KURSEXPLOSION bei Biotech-Aktie! BioNTech, Evotec, Nyxoah | Geht es bei Evotec jetzt doch ganz schnell? Ein Finanzinvestor positioniert sich jedenfalls für eine Übernahme und die Aktie schoss zuletzt kräftig nach oben. Ist damit die Enttäuschung über die Quartalszahlen... ► Artikel lesen | |
| QUANTUM-SI | 1,400 | 0,00 % | Nvidia Partners With Quantum-Si To Advance Single-Molecule Analysis | ||
| QIAGEN | 39,720 | +2,27 % | Neue 6,00% Aktienanleihe mit Barriere auf QIAGEN in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VC7RDU1/ WKN VC7RDU) mit Barriere auf die Aktie von QIAGEN (ISIN... ► Artikel lesen | |
| 89BIO | 7,980 | 0,00 % | 89bio, Inc.: 89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting 2024 | SAN FRANCISCO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for... ► Artikel lesen | |
| LONGBOARD PHARMACEUTICALS | 59,76 | 0,00 % | Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates | LA JOLLA, Calif.--(BUSINESS WIRE)--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological... ► Artikel lesen | |
| RELAY THERAPEUTICS | 4,660 | 0,00 % | Aktie von Relay Therapeutics erreicht 52-Wochen-Tief bei 5,59 US-Dollar | ||
| STRUCTURE THERAPEUTICS | 32,710 | 0,00 % | Structure Therapeutics reports Q3 results | ||
| SPRINGWORKS THERAPEUTICS | 37,440 | 0,00 % | SpringWorks started at outperform by Evercore ahead of FDA decision | ||
| 4D MOLECULAR THERAPEUTICS | 8,410 | 0,00 % | Analyst Expectations For 4D Molecular Therapeutics' Future | ||
| DYNE THERAPEUTICS | 30,000 | 0,00 % | Dyne Therapeutics: Leitender Vizepräsident veräußert Aktien im Wert von 77.127 US-Dollar | ||
| CULLINAN THERAPEUTICS | 12,580 | 0,00 % | Cullinan Therapeutics, Inc.: Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024 | Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of CLN-978 in autoimmune diseases Cullinan will share details of global Phase... ► Artikel lesen | |
| VIR BIOTECHNOLOGY | 6,740 | 0,00 % | Needham & Company LLC Reaffirms Buy Rating for Vir Biotechnology (NASDAQ:VIR) | ||
| VERVE THERAPEUTICS | 4,550 | 0,00 % | Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | BOSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on October 31, 2024... ► Artikel lesen |
AQUAPORIN A/S gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 2,930 Euro und damit +0,34 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AQUAPORIN A/S finden Sie auf Wallstreet Online.
